We are live on ! Find out more
CYNA

CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA

Delisted

CYNA was delisted on the 20th of October, 2016.

31 hedge funds and large institutions have $85.2M invested in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

3% more funds holding

Funds holding: 3031 (+1)

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

20% less capital invested

Capital invested by funds: $107M → $85.2M (-$21.7M)

Holders
31
Holders Change
+1
Holders Change %
+3.33%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
7
Increased
7
Reduced
7
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
26
Bank of America
North Carolina
$3K -$17.2K -1,286 -84%
Creative Planning
27
Creative Planning
Kansas
$3K
Morgan Stanley
28
Morgan Stanley
New York
$1K +$1.33K +99 +471%
BC
29
Broadfin Capital
New York
-$8.92M -583,121 Closed
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
-$209K -13,511 Closed
SIM
31
Spark Investment Management
New York
-$171K -11,200 Closed
Walleye Trading
32
Walleye Trading
New York
-$9K -600 Closed
TRCT
33
Tower Research Capital (TRC)
New York
-$2K -140 Closed
Barclays
34
Barclays
United Kingdom
-$2K -100 Closed
Toronto Dominion Bank
35
Toronto Dominion Bank
Ontario, Canada
-$469 -35 -59%
Citigroup
36
Citigroup
New York
+$228 +17 New
DOA
37
D'Orazio & Associates
Virginia
+$830 +62 New

CYNA Hedge Fund Activity: Q1 2016 in Review

31 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) for Q1 2016, worth a combined $85.2M — down 20% from $107M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CYNA positions and 6 closed out — a net gain of 1 holder — while 7 added to existing stakes and 7 trimmed.

The largest buyer was Visium Asset Management, opening a new position worth an estimated $10M. The largest seller was Broadfin Capital, exiting entirely with an estimated $8.92M sold.

  • 31 institutional investors held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) as of Q1 2016, up from 30 in Q4 2015.
  • Funds reported $85.2M of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) stock for Q1 2016, down 20% quarter-over-quarter.
  • 7 funds opened new CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) positions in Q1 2016 and 6 closed out, a net change of +1 holder.
  • The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) buyer in Q1 2016 was Visium Asset Management, an estimated $10M added.
  • The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) seller in Q1 2016 was Broadfin Capital, an estimated $8.92M sold.

Based on aggregated 13F filings for Q1 2016.